Crystal structure of CTX-M-14 with compound 3

Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery.

(PCA)TSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPAD
LVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTT
TPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVT
YFTQPQQNAESRRDVLASAARIIAEGL

QTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNY
NPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRA
MAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQ
PQQNAESRRDVLASAARIIAEGL

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

Fri Sep 11 04:46:07 2015 (svn Unversioned directory)

Tetrazole, inhibitor, complex, Extended spectrum beta-lactamase, HYDROLASE, HYDROLASE-INHIBITOR complex